Loading…
Underlying
Underlying Price
$8.28
Type
Call
Strike
9.5
Expiration
Nov 13, 2026
DTE
24d
Moneyness
OTM
Intrinsic
$0.00
IBRX 9.5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $0.28 | -65.00% | 263 | 586 |
| Oct 30, 2026 | 10d | $1.24 | +1.64% | 8 | 239 |
| Nov 6, 2026 | 17d | $0.70 | -48.91% | 22 | 45 |
| Nov 13, 2026 | 24d | $0.88 | -39.73% | 214 | 382 |
| Nov 27, 2026 | 38d | $1.20 | -41.46% | 12 | 58 |
IBRX Nearby Strikes · Nov 13, 2026
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.